Jennifer Seggev

Transformational marketing leader with broad oncology strategy development and execution success in both biopharma and healthcare organizations with expertise in Global and US Oncology Marketing.  Depth of oncology expertise spanning both solid tumors and hematologic malignancies.  Exceptional relationship building with internal and external stakeholders. Strong sense of urgency to deliver value for the betterment of cancer patients’ lives. Dedication to mentoring those around me to deliver individual and business growth. 

As an accomplished marketing leader with extensive experience in oncology strategy development, I currently serve as Vice President and Head of New Product Planning for the Global Oncology Business Franchise at Merck KGaA, Darmstadt, Germany. My expertise spans both solid tumors and hematologic malignancies, where I have successfully architected end-to-end strategies for innovative therapies, driving significant value for patients. With a proven track record in commercial leadership across both pharma and healthcare organizations, I excel in cross-functional collaboration and fostering strategic partnerships, alongside a strong commitment to mentoring and promoting gender diversity in the workplace. My dedication to enhancing patient outcomes and delivering impactful marketing strategies positions me as a strong candidate for a VP role.

I hold an MBA in Marketing and Market Research from the University of California, Irvine, Merage School of Business, and a Bachelor of Science in Biochemistry and Molecular Biology from the University of California, Santa Barbara. My educational background equips me with a strong foundation in both scientific principles and strategic marketing, essential for driving successful initiatives in the oncology field.